| 1.47 0.16 (12.21%) | 08-07 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.92 | 1-year : | 2.17 |
| Resists | First : | 1.64 | Second : | 1.86 |
| Pivot price | 1.44  |
|||
| Supports | First : | 1.3 | Second : | 1.08 |
| MAs | MA(5) : | 1.41 |
MA(20) : | 1.48 |
| MA(100) : | 2.38 |
MA(250) : | 3.98 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 25.6 |
D(3) : | 23 |
| RSI | RSI(14): 44.5 |
|||
| 52-week | High : | 8.58 | Low : | 1.25 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NYXH ] has closed below upper band by 39.0%. Bollinger Bands are 70.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 29 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.36 - 1.37 | 1.37 - 1.38 |
| Low: | 1.28 - 1.29 | 1.29 - 1.3 |
| Close: | 1.29 - 1.31 | 1.31 - 1.33 |
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Sat, 08 Aug 2026
Nyxoah SA (EBR:NYXH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - simplywall.st
Fri, 07 Aug 2026
Stifel maintains Hold on Nyxoah stock, cites cash flow concerns - investing.com
Thu, 06 Aug 2026
Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating - marketscreener.com
Thu, 06 Aug 2026
Nyxoah SA Revenue Breakdown – EURONEXT:NYXH - tradingview.com
Thu, 06 Aug 2026
Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ... - Yahoo Finance
Wed, 05 Aug 2026
Nyxoah Q2 Earnings Call Highlights - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 100 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 33.7 (%) |
| Held by Institutions | 26.8 (%) |
| Shares Short | 413 (K) |
| Shares Short P.Month | 826 (K) |
| EPS | -2.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.93 |
| Profit Margin | 0 % |
| Operating Margin | -321.8 % |
| Return on Assets (ttm) | -44.6 % |
| Return on Equity (ttm) | -130 % |
| Qtrly Rev. Growth | 498.8 % |
| Gross Profit (p.s.) | 0.09 |
| Sales Per Share | 0.15 |
| EBITDA (p.s.) | -0.82 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -72 (M) |
| Levered Free Cash Flow | -46 (M) |
| PE Ratio | -0.61 |
| PEG Ratio | 0 |
| Price to Book value | 1.56 |
| Price to Sales | 9.59 |
| Price to Cash Flow | -2.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|